JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trifilo, M. J.
Right arrow Articles by Lane, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trifilo, M. J.
Right arrow Articles by Lane, T. E.

 Previous Article  |  Next Article 

Journal of Virology, April 2003, p. 4004-4014, Vol. 77, No. 7
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.7.4004-4014.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection

Matthew J. Trifilo,1 Cornelia C. Bergmann,2 William A. Kuziel,3 and Thomas E. Lane1*

Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California 92697-3900,1 Departments of Neurology and Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033,2 Section of Molecular Genetics and Microbiology and Institute for Cellular and Molecular Biology, University of Texas, Austin, Austin, Texas 787123

Received 17 June 2002/ Accepted 31 December 2002

Chemokines induce the directional migration of targeted populations of leukocytes during periods of inflammation. Moreover, these molecules also regulate T-cell activation and differentiation following antigenic stimulation. In the present study, the contributions of the CC chemokine ligand 3 (CCL3) to the differentiation and migration of effector T cells in response to viral infection of the central nervous system (CNS) were analyzed. CCL3-/- mice infected with mouse hepatitis virus exhibited a significant reduction of virus-specific CD8+ T cells within the CNS, correlating with delayed viral clearance. Decreased infiltration of CD8+ T cells into infected CCL3-/- mice was associated with enhanced accumulation of primed CD8+ T cells in cervical lymph nodes. Although virus-specific CD8+ T cells from CCL3-/- mice were CD44high, they remained CD62Lhigh and CD25low, retained CCR7 expression, and contained limited transcripts of the proinflammatory chemokine receptors CCR5 and CXCR3 compared with virus-specific CD8+ T cells from CCL3+/+ mice. Furthermore, the absence of CCL3 impaired the cytokine production and cytolytic activity of CD8+ T cells. In addition, macrophage accumulation within the CNS was significantly decreased in infected CCL3-/- mice, correlating with reduced demyelination. These results suggest that CCL3 not only mediates macrophage chemotaxis but also significantly enhances differentiation of primed CD8+ T cells into effector cells and their release into circulation, thus potentiating effective migration to the site of infection.


* Corresponding author. Mailing address: Department of Molecular Biology and Biochemistry, 3205 McGaugh Hall, University of California, Irvine, Irvine, CA 92697-3900. Phone: (949) 824-5878. Fax: (949) 824-8551. E-mail: tlane{at}uci.edu.


Journal of Virology, April 2003, p. 4004-4014, Vol. 77, No. 7
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.7.4004-4014.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.